2686 Federal Register / Vol. 86, No. 8 / Wednesday, January 13, 2021 / Notices 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 7, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–00495 Filed 1–12–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Dental Fear and Anxiety 

RFA Review Meeting. 

Date: February 26, 2021. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Dental and 

Craniofacial Research, National Institutes of 

Health, 6701 Democracy Boulevard, Suite 

668, Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Nisan Bhattacharyya, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute of Dental 

and Craniofacial Research, National Institutes 

of Health, 6701 Democracy Boulevard, Suite 

668, Bethesda, MD 20892, 301–451–2405, 

nisan_bhattacharyya@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: January 7, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–00494 Filed 1–12–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; A Solicitation of the 

National Institutes of Health (NIH) and the 

Centers for Disease Control and Prevention 

(CDC) for Small Business Innovation 

Research (SBIR) Contract Proposals (N01), 

Topic 88 Phase II. 

Date: January 21, 2021. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G21A, 

Rockville, MD 20892 (Telephone Conference 

Call). 

Contact Person: Dimitrios Nikolaos 

Vatakis, Ph.D., Scientific Review Officer, 

Scientific Review Program, National Institute 

of Allergy and Infectious Diseases, National 

Institutes of Health, 5601 Fishers Lane, Room 

3G21A, Rockville, MD 20892, 301–761–7176, 

dimitrios.vatakis@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; HHS–NIH–CDC–SBIR PHS 

2021–1: Therapeutic Targeting of 

Intracellular HIV–1 Proteins or Nucleic Acids 

(Topic 88). 

Date: January 21, 2021. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G21A, 

Rockville, MD 20892 (Telephone Conference 

Call). 

Contact Person: Dimitrios Nikolaos 

Vatakis, Ph.D., Scientific Review Officer, 

Scientific Review Program, National Institute 

of Allergy and Infectious Diseases, National 

Institutes of Health, 5601 Fishers Lane, Room 

3G21A, Rockville, MD 20892, 301–761–7176, 

dimitrios.vatakis@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; A Solicitation of the 

National Institutes of Health (NIH) and the 

Centers for Disease Control and Prevention 

(CDC) for Small Business Innovation 

Research (SBIR) Contract Proposals (N01), 

Topic 89. 

Date: January 22, 2021. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G21A, 

Rockville, MD 20892 (Telephone Conference 

Call). 

Contact Person: Dimitrios Nikolaos 

Vatakis, Ph.D., Scientific Review Officer, 

Scientific Review Program, National Institute 

of Allergy and Infectious Diseases, National 

Institutes of Health, 5601 Fishers Lane, Room 

3G21A, Rockville, MD 20892, 301–761–7176, 

dimitrios.vatakis@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; HHS–NIH–CDC–SBIR PHS 

2021–1: Particle-based Co-delivery of HIV 

immunogens as Next-generation HIV 

Vaccines (Topic 89). 

Date: January 22, 2021. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G21A, 

Rockville, MD 20892 (Telephone Conference 

Call). 

Contact Person: Dimitrios Nikolaos 

Vatakis, Ph.D., Scientific Review Officer, 

Scientific Review Program, National Institute 

of Allergy and Infectious Diseases, National 

Institutes of Health, 5601 Fishers Lane, Room 

3G21A, Rockville, MD 20892, 301–761–7176, 

dimitrios.vatakis@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 8, 2021. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–00545 Filed 1–12–21; 8:45 am] 

BILLING CODE 4140–01–P